UY34032A - Nuevos inhibidores de quinasa - Google Patents
Nuevos inhibidores de quinasaInfo
- Publication number
- UY34032A UY34032A UY34032A UY34032A UY34032A UY 34032 A UY34032 A UY 34032A UY 34032 A UY34032 A UY 34032A UY 34032 A UY34032 A UY 34032A UY 34032 A UY34032 A UY 34032A
- Authority
- UY
- Uruguay
- Prior art keywords
- new
- quinasa
- inhibitors
- quinasa inhibitors
- página
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención se relaciona con nuevos compuestos de fórmula (I) capaces de inhibir una o más quinasas, especialmente SYK (tirosina quinasa esplénica), LRRK2 (quinasa con repeticiones ricas en leucina 2) y/o MYLK (quinasa de cadena ligera de miosina) o mutantes de estas. Los compuestos encuentran aplicación en el tratamiento de una variedad de enfermedades. Estas enfermedades incluyen enfermedades autoinmunes, enfermedades inflamatorias, enfermedades óseas, metabólicas, neurológicas y neurodegenerativas, cáncer, enfermedades cardiovasculares, alergias, asma, enfermedad de Alzheimer, enfermedad de Parkinson, trastornos de la piel, enfermedades del ojo, enfermedades infecciosas y enfermedades hormonales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11003373 | 2011-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY34032A true UY34032A (es) | 2012-11-30 |
Family
ID=44501589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY34032A UY34032A (es) | 2011-04-21 | 2012-04-20 | Nuevos inhibidores de quinasa |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR086196A1 (es) |
UY (1) | UY34032A (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2936377A1 (en) | 2014-01-10 | 2015-07-16 | Shanghai Birdie Biotech, Inc. | Compounds and compositions for treating egfr expressing tumors |
CN106943597A (zh) | 2016-01-07 | 2017-07-14 | 博笛生物科技(北京)有限公司 | 用于治疗肿瘤的抗-egfr组合 |
MA47079B1 (fr) | 2016-12-20 | 2021-05-31 | Astrazeneca Ab | Composés amino-triazolopyidines et leur utilisation pour traiter le cancer |
CN108794467A (zh) | 2017-04-27 | 2018-11-13 | 博笛生物科技有限公司 | 2-氨基-喹啉衍生物 |
WO2018232725A1 (en) | 2017-06-23 | 2018-12-27 | Birdie Biopharmaceuticals, Inc. | PHARMACEUTICAL COMPOSITIONS |
-
2012
- 2012-04-20 UY UY34032A patent/UY34032A/es active IP Right Grant
- 2012-04-20 AR ARP120101360 patent/AR086196A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR086196A1 (es) | 2013-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY33925A (es) | Inhibidores tricíclicos de quinasas | |
UY34559A (es) | Inhibidores de bromodominios | |
UY34374A (es) | Benzilindazoles sustituidos | |
UY34156A (es) | Compuestos inhibidores de metaloenzimas | |
UY34034A (es) | Triazolopiridinas | |
UY34039A (es) | Compuestos fungicidas | |
UY34004A (es) | INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO[2,3-d]PIRIMIDINA TROPOMIOSINA | |
UY34515A (es) | Triazolopiridinas sustituidas | |
UY34051A (es) | Derivados de pirrolotriazinona como inhibidores de pi3k | |
UY33958A (es) | Inhibidores de la glucosilceramida sintasa | |
UY34006A (es) | Imidazopiridazinas | |
UY34550A (es) | Bencilpirazoles sustituidos | |
UY34145A (es) | Compuestos inhibidores de metaloenzimas | |
UY34146A (es) | Compuestos inhibidores de metaloenzimas | |
UY33930A (es) | Inhibidores novedosos de quinasas | |
UY33978A (es) | Piridinonas bicíclicas nuevas. | |
UY4149Q (es) | Golosina para mascota | |
UY33943A (es) | Derivados espirocíclicos de isoxazolina como agentes antiparasitarios. | |
UY34092A (es) | Nuevos compuestos como inhibidores de jak | |
UY34472A (es) | Derivados modificados de 4-fenil-piridina | |
UY34352A (es) | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante | |
UY34763A (es) | Inhibidores de la agregación plaquetaria | |
UY34027A (es) | Inhibidores sustituidos de acetil-coa carboxilasa. | |
UY33929A (es) | Compuestos de ciclohexilo tetrasustituido como inhibidores de quinasas | |
UY34817A (es) | Tienopirimidinas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
110 | Patent granted |
Effective date: 20211028 |